Home > Insider Trading > Filing (0001209191-14-070835)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1182129	Auxilium Pharmaceuticals Inc	AUXL	Pharmaceutical Preparations (2834)	233016883

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1527710	Patrick James Tursi	C/O Auxilium Pharmaceuticals, Inc. 640 Lee Road Chesterbrook PA 19087	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-11-20	37,500	$14.10	76,203	No	4	M	Direct
Common Stock	Acquisiton	2014-11-20	28,500	$19.51	104,703	No	4	M	Direct
Common Stock	Acquisiton	2014-11-21	5,000	$22.04	109,703	No	4	M	Direct
Common Stock	Disposition	2014-11-20	6,200	$32.94	103,503	No	4	S	Direct
Common Stock	Disposition	2014-11-20	59,800	$33.18	43,703	No	4	S	Direct
Common Stock	Disposition	2014-11-21	3,648	$33.45	40,055	No	4	S	Direct
Common Stock	Disposition	2014-11-21	5,000	$33.49	35,055	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonqualified Stock Option (Right to Buy)	Disposition	2014-11-20	37,500	$0.00	37,500	$14.10
Common Stock	Nonqualified Stock Option (Right to Buy)	Disposition	2014-11-20	28,500	$0.00	28,500	$19.51
Common Stock	Nonqualified Stock Option (Right to Buy)	Disposition	2014-11-21	5,000	$0.00	5,000	$22.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500	2012-08-08	2021-08-08	No	4	M	Direct
28,500	2013-02-14	2022-02-13	No	4	M	Direct
4,750	2012-02-17	2021-02-17	No	4	M	Direct

Footnotes

Includes 498 shares acquired under the Auxilium Pharmaceuticals, Inc. 2006 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.925 to $32.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.32, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.40 to $33.525, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $33.53, inclusive.